K One MM 2 mg/0.2 ml Injection
The usual dose for neonates is 2 mg orally at or just after birth. Then 2 mg on 4th - 5th day and another 2 mg on 28th - 30th day orally.
:
Out of stock
In stock – ready to ship
Delivery
Inside Dhaka: 1–2 days · Outside Dhaka: 2–4 days
Cash on Delivery
Pay when you receive your order.
Returns
Easy 7-day return & exchange
- Category
- fals Injection
- Brand
- Square Pharmaceuticals PLC
Product details
MM 2 mg/0.2 ml Injection
Prophylaxis: Mild Hemorrhage or hemorrhagic tendency: The usual dose for neonates is 2 mg orally at or just after birth. Then 2 mg on 4th - 5th day and another 2 mg on 28th - 30th day orally. If the oral route is unsuitable then 2 mg of drug can be administered by IM or IV route. Children over 1 year of age are could be given 5-10 mg orally. Intramuscular and intravenous doses should not exceed 0.4 mg/kg in premature infants weighing less than 2.5 kg. The size and frequency of further doses should be based on coagulation status.
Generic
Phytomenadione
Indications
Phytomenadione (Vitamin K-1) is shown in taking after indications-
- Prophylaxis and treatment of haemorrhagic illness within the newborn.
- Haemorrhage or hazard of discharge as a result of extreme hypoprothrombinemia (i.e. lack of clotting components II, VII, IX and X) of different etiologies, counting overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other shapes of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disarranges, and after delayed treatment with anti-microbials, sulphonamides or salicylates).
- Prevention and treatment of dying due to vitamin K deficiency.
Pharmacology
Phytomenadione could be a procoagulant figure. As a component of a hepatic carboxylase framework, Phytomenadione is included within the post translational carboxylation of clotting variables II (prothrombin), VII, IX and X and the clotting inhibitors protein C and protein S.
Interaction
Phytomenadione offends the impact of coumarin-type anticoagulants. Coadministration of anticonvulsants can disable the activity of vitamin K-1. ContraindicationsIt is contraindicated in patients with known touchiness to any of its constituents.
Side Effects
There are disconnected unverified reports on the conceivable event of anaphylactoid responses and venous aggravation or phlebitis after parenteral utilize of Phytomenadione infusions. Pregnancy & LactationCautious observing of the coagulation parameters is essential for patients with seriously impeded liver work after organization of Phytomenadione.
Precautions & Warnings
Cautious checking of the coagulation parameters is fundamental for patients with seriously impeded liver work after organization of Phytomenadione .
Therapeutic Class
Vitamin-K Preparations
Storage Conditions
Keep below 30°C temperature, absent from light & dampness. Keep out of the reach of children.
Pharmaceutical Name
Square Pharmaceuticals Ltd.
0 reviews
⭐
No reviews yet
Bought this product? Share your experience to help others.
You may also like
Recently viewed
K One MM 2 mg/0.2 ml Injection
৳119